Bicocca Open Archive

Logo unimib boa
CRISTOFERI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.940
EU - Europa 2.126
AS - Asia 632
SA - Sud America 9
AF - Africa 3
Totale 5.710
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.924
IT - Italia 701
DE - Germania 369
SE - Svezia 336
IE - Irlanda 262
SG - Singapore 229
RU - Federazione Russa 159
CN - Cina 154
GB - Regno Unito 143
HK - Hong Kong 112
IN - India 38
VN - Vietnam 32
FI - Finlandia 26
FR - Francia 26
DK - Danimarca 20
UA - Ucraina 17
MY - Malesia 16
CA - Canada 15
NL - Olanda 14
BE - Belgio 13
ID - Indonesia 10
TR - Turchia 10
AT - Austria 8
BR - Brasile 7
ES - Italia 7
IL - Israele 7
CZ - Repubblica Ceca 6
NO - Norvegia 6
TW - Taiwan 6
MM - Myanmar 4
IQ - Iraq 3
KR - Corea 3
SK - Slovacchia (Repubblica Slovacca) 3
CH - Svizzera 2
GH - Ghana 2
GR - Grecia 2
IR - Iran 2
JP - Giappone 2
LT - Lituania 2
PK - Pakistan 2
AR - Argentina 1
BG - Bulgaria 1
EC - Ecuador 1
EE - Estonia 1
LK - Sri Lanka 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
Totale 5.710
Salva come PNG Salva come JPEG
Città #
Ann Arbor 862
Frankfurt am Main 336
Milan 258
Dublin 248
Fairfield 231
Chandler 220
Singapore 197
Wilmington 178
New York 124
Ashburn 118
Hong Kong 106
Chicago 105
Woodbridge 104
London 88
Seattle 85
Houston 84
Cambridge 81
Princeton 72
Shanghai 61
Santa Clara 58
Dearborn 44
Lawrence 35
Rome 31
Altamura 28
Florence 25
Beijing 24
Boardman 21
Helsinki 20
San Diego 20
Pune 17
Monza 16
Penang 16
Nanjing 15
Los Angeles 14
Jacksonville 13
Andover 12
Brussels 12
Turin 12
Jakarta 10
Bologna 9
Bari 8
Mumbai 8
Paris 8
Fremont 7
Guangzhou 7
Modena 7
Naples 7
Brno 6
Central 6
Desio 6
Detroit 6
Kocaeli 6
Lissone 6
Padova 6
Toronto 6
Cagliari 5
Genoa 5
Lappeenranta 5
São Paulo 5
Vienna 5
Appiano Gentile 4
Castiglione del Lago 4
Council Bluffs 4
Dong Ket 4
Jiaxing 4
Jinan 4
Kilburn 4
Meda 4
Norwalk 4
Shenyang 4
Udine 4
Bratislava 3
Carate Brianza 3
Changsha 3
Chioggia 3
Comazzo 3
Cossato 3
Edmonton 3
Falls Church 3
Garbagnate Milanese 3
Giv‘at Shmuel 3
Hangzhou 3
Hebei 3
Hounslow 3
Huizen 3
Kunming 3
Lodi 3
Lucca 3
Moscow 3
New Taipei 3
Oslo 3
Taipei 3
Terni 3
Vigevano 3
Washington 3
Wuhan 3
Aalsmeer 2
Accra 2
Acquaviva delle Fonti 2
Agrate Brianza 2
Totale 4.262
Salva come PNG Salva come JPEG
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 410
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 229
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 207
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 186
Precision medicine in primary biliary cholangitis 182
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 177
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 173
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 163
Risk stratification in primary sclerosing cholangitis 162
Endocrinology and Metabolic Diseases (Including Diabetes) 160
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies 160
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 160
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 155
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 150
New Therapeutic Targets in Autoimmune Cholangiopathies 148
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 139
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 136
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 135
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 134
Prognostic models in primary biliary cholangitis 132
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study 124
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat 120
Comment on "Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis" 120
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 120
The immunobiology of female predominance in primary biliary cholangitis 115
RADIOLOGY-BASED BIOMARKERS DISCOVERY IN PRIMARY SCLEROSING CHOLANGITIS: FROM RISK STRATIFICATION TO THE EVALUATION OF TREATMENT BENEFIT 104
Fibrocystic liver disease 103
Geoepidemiology and (epi-)genetics in primary biliary cholangitis 98
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 98
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 85
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 82
Individualizing Care: Management Beyond Medical Therapy 76
A Smooth Esophageal Stricture Causing Dysphagia 76
Prevalence of upper gastrointestinal endoscopic findings in the community: A systematic review of studies in unselected samples of subjects 72
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 72
Antioxidant treatment for acute pancreatitis 69
Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis 64
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 59
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 57
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 56
Transient elastography in chronic liver disease: beware to the cut-offs! 56
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 51
Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease? 49
Artificial intelligence for precision medicine in autoimmune liver disease 46
An update on novel pharmacological agents for primary sclerosing cholangitis 43
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis 41
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis 41
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know 38
X marks the spot in autoimmunity 37
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? 36
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score 35
Systematic review-Pancreatic involvement in inflammatory bowel disease 34
The Role of Epigenetics in Primary Biliary Cholangitis 34
The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis 32
Primary Sclerosing Cholangitis 29
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 28
Elastography in Autoimmune Liver Diseases 26
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement 19
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 18
Individualizing Care: Management Beyond Medical Therapy 17
Cluster analysis reveals the prognostic role of serum albumin within the normal range in patients with primary biliary cholangitis 15
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 15
European Society for Organ Transplantation (ESOT) Consensus Statement on Outcome Measures in Liver Transplantation According to Value-Based Health Care 14
A NOVEL MACHINE-LEARNING, COMMON VARIANTS-BASED APPROACH TO PREDICT PRIMARY BILIARY CHOLANGITIS 14
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 11
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 9
Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis 8
Totale 6.064
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.008
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020530 0 0 30 49 61 65 80 59 59 69 42 16
2020/20211.133 29 25 184 66 88 121 101 130 89 78 115 107
2021/2022772 100 98 140 80 43 41 14 42 39 32 53 90
2022/20231.439 118 329 125 93 152 181 108 69 101 47 76 40
2023/20241.363 45 65 67 134 145 271 181 28 69 98 45 215
2024/2025602 195 303 104 0 0 0 0 0 0 0 0 0
Totale 6.064